Aigen Investment Management’s Maravai LifeSciences MRVI Stock Holding History

Aigen Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.1K	Buy	+15,594	New	+$52.9K	0.01%	489
2025 Q2	–	Sell	-16,754	Closed	-$37K	–	968
2025 Q1	$37K	Buy	+16,754	New	+$66.2K	0.01%	722
2024 Q3	–	Sell	-30,192	Closed	-$216K	–	911
2024 Q2	$216K	Buy	30,192 +5,901	+24%	+$50.9K	0.04%	604
2024 Q1	$211K	Sell	24,291 -16,631	-41%	-$113K	0.05%	530
2023 Q4	$268K	Buy	+40,922	New	+$264K	0.05%	534
2023 Q2	–	Sell	-17,354	Closed	-$243K	–	897
2023 Q1	$243K	Buy	+17,354	New	+$249K	0.03%	477

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aigen Investment Management's MRVI Position: Q1 2026 in Review

Aigen Investment Management opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 15,594 shares worth $44.1K. The stake represents 0.01% of the portfolio and ranks #489 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in MRVI as recently as Q1 2025.

Aigen Investment Management first reported a position in MRVI in Q1 2023 and has held it in 6 quarters since. The position peaked at $268K in Q4 2023. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Aigen Investment Management held 15,594 shares of Maravai LifeSciences worth $44.1K as of Q1 2026.
Maravai LifeSciences was a new Aigen Investment Management position in Q1 2026.
Maravai LifeSciences made up 0.01% of Aigen Investment Management's portfolio in Q1 2026, its #489 holding.
Aigen Investment Management first reported a position in Maravai LifeSciences in Q1 2023 and has held it in 6 quarters since.
Aigen Investment Management's Maravai LifeSciences position peaked at $268K in Q4 2023.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.